Skip to main content
. 2002 Nov;184(22):6235–6249. doi: 10.1128/JB.184.22.6235-6249.2002

TABLE 2.

Lethality of lexA null mutations in strain LT2

Transductional recipient
No. of selected transductants obtained with indicated donor (constant phage input, 3 × 109 PFU)
Strain Relevant genotype Genetic background if other than LT2 lexA40::Kan (TT17653)a lexA41::Cam (TT22613)b (Cam)lexA33(Ind) (TT22964)b
TR10000 Wild type (LT2) recA+lexA+ 1c 3c 444
TT23205 sulA46::Spc 12d 22d 524
TT23204 sulA46::Spc (no Fels-2 or Gifsy-1 or -2) SLT2 476 368 492
TT22888 Duplication (lexA+/lexA+) 348 396 532
TT23203 sulA46::Spc duplication (lexA+/lexA+) 460 364 428
TT23296 sulA46::Spc (no Fels-2 or Gifsy-1 or -2) DB9071 480 512 500
TT23298 sulA46::Spc (no Gifsy-2) ATCC 14028 43d 6d 552
TT23299 sulA46::Spc (no Gifsy-1 or -2) ATCC 14028 20d 10d 548
TT23379 sulA46::Spc (no Fels-2) DB7000 340e 516e 515
TT23649 tum(Fels-2)::Cam(sw) sulA+ 3c (656)f
TT23650 tum(Fels-2)::Cam(sw) sulA46::Spc 306e (678)f
a

Selection was for resistance to kanamycin on NB containing 50 μg of kanamycin per ml.

b

Selection was for resistance to chloramphenicol (Cam) on NB containing 25 μg of chloramphenicol per ml.

c

Healthy colonies that contained a duplication of the lexA gene.

d

Mixture of healthy colonies and flat, small colonies. Healthy colonies contained a duplication of the lexA gene.

e

Colonies were virtually all flat and small.

f

Since this recipient was already Camr, a hisC::Kan (TT16803) marker strain was used as the donor instead of (Cam)lexA33; transductants were selected on NB containing kanamycin (50 μg/ml).